Abbott (ABT) Receives FDA's Breakthrough Device Designation For Exploring Deep Brain Stimulation To Manage Severe DepressionPulse2 • 07/12/22
Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe DepressionPRNewsWire • 07/12/22
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/06/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/05/22
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/01/22
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmBusiness Wire • 06/30/22
Strength Seen in Abbott (ABT): Can Its 3.1% Jump Turn into More Strength?Zacks Investment Research • 06/27/22
ABBOTT LABORATORIES INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties – ABTBusiness Wire • 06/23/22
FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant ReopensBenzinga • 06/23/22
7 ‘Strong Buy' Dividend Aristocrats Are Safe-Haven Stocks to Own During a Recession24/7 Wall Street • 06/21/22